Somewhere between the first “you look tired” and the first photo where the frown line didn’t fade, a lot of women start googling the same question.

Is it too early for Botox?

The word attached to that search is usually preventative. It gets used constantly and explained almost never. So a fair question — can a treatment stop a wrinkle that hasn’t formed yet? — ends up buried under marketing language. The honest answer is more interesting than the pitch. And it has surprisingly little to do with age.

Lines Start as Movement, Not as Damage

Every expression is a muscle pulling on skin. Raising the eyebrows folds the forehead. Concentrating pulls the brows together. Smiling gathers little pleats at the outer corners of the eyes.

In early adulthood, that skin springs back the instant the expression ends. Collagen and elastin — the proteins that give skin its structure and bounce — erase the fold immediately. Nothing is left behind.

What changes over time isn’t the movement. It’s the recovery.

Collagen declines slowly but steadily through adult life, roughly one percent a year, and sun exposure speeds that up considerably. The same fold that used to vanish now takes a second to smooth out. Then a few seconds. Then it stops fully smoothing out at all.

Aesthetic medicine has names for the two stages. A dynamic line shows up only when the face moves. A static line is visible at rest, on a completely relaxed face. Most static lines on the upper face begin life as dynamic ones.

What “Preventative” Is Really Describing

Botox and the other wrinkle relaxers work on the signal, not the skin. The active ingredient temporarily blocks the chemical messenger that tells a specific muscle to contract. The muscle pulls more softly, so the skin above it folds less sharply. Over three to four months the nerve recovers its ability to send that signal, and normal movement returns.

So nothing is being prevented in the vaccine sense. What the treatment reduces is repetition — thousands of daily folds along the same crease line. Fold the paper less often, and it takes far longer to hold a permanent crease.

The best-known evidence for this idea is a strange little study, cited constantly and understood rarely.

In 2006, Archives of Facial Plastic Surgery published a comparison of identical twin sisters. One had been treated regularly on the forehead and between the brows for thirteen years. The other had received just two treatments in that entire period. The difference at rest was plain: the imprinted lines visible on the minimally treated twin were not there on her sister. A follow-up nineteen years in found the same pattern.

Striking — and still just two people, in a study whose author has industry ties. It points in a direction rather than proving a rule.

One more thing worth saying plainly: regulators have never approved these products as preventative. FDA approvals cover the temporary improvement of lines that already exist.

Forget Age. Look at Your Face at Rest.

“What age should I start?” is the most common version of this question — and the least useful one. Genetics, sun history, skin tone, and how expressive a face naturally is can move the timeline by a decade in either direction.

There’s a simpler test, and it takes thirty seconds.

Relax your face completely in front of a mirror. Not neutral-ish — properly still, no expression at all. Now look at the forehead, the space between the brows, and the corners of the eyes.

Lines gone entirely? They’re still dynamic, which generally means there’s no rush — though only an in-person assessment can say for certain. A faint shadow still there? That crease may have started its transition.

That transition is exactly what early treatment aims at. And it arrives at wildly different ages for different people.

What Starting Earlier Does Not Do

This is where expectations go sideways.

Wrinkle relaxers address lines caused by muscle movement. That’s it. A face ages through several separate processes at once, and a neurotoxin touches exactly one of them. It won’t fix:

• Sun damage. Discoloration, rough patches, and broken capillaries have nothing to do with muscles.
• Lost volume. Hollowing in the cheeks or under the eyes is a different process with different treatments.
• Texture and dark spots. Those live in the skin itself, not in the movement beneath it.
• Crepey fine lines. These come from thinning skin, not folding — relaxing a muscle does little there.

Starting earlier also doesn’t mean treating more. Muscles that stay switched off for years can weaken and thin — fine in the frown area, less fine in a forehead that also holds the eyebrows up. And a small number of people eventually develop antibodies that make treatment less effective, though this is genuinely rare at cosmetic doses.

Neither problem is common. Both are reasons “more, sooner” is a poor strategy.

Dose and Placement Matter More Than Timing

Early treatment done properly looks like restraint: smaller amounts, placed precisely, softening a movement rather than erasing it. The frozen look people fear rarely comes from a small, well-placed dose. It comes from a large one in the wrong place.

These are also prescription medications with real side effects. Bruising, headache, and a temporary droop of an eyelid or brow are the common ones; effects beyond the injection site are possible but uncommon — though serious enough that the label carries the FDA’s strongest warning about them. That’s why the assessment matters as much as the injection.

And the assessment is everything. Facial muscles vary meaningfully from person to person in strength, size, and position, and the injector’s read of one particular face decides whether the result looks rested or looks done. It’s why medically supervised wrinkle relaxer treatments are worth seeking out specifically — the standard to look for is a licensed medical injector, working under physician oversight, who maps that anatomy before deciding on a single unit.

A conservative first appointment is a good sign, not hesitation. Product can be added at a two-week follow-up. It cannot be removed.

Questions Worth Asking First

A consultation should feel like a conversation, and a few questions reveal a lot:

• Who performs the injection, and what are their medical credentials?
• Which product is being recommended for this particular face, and why?
• What should the result look like at two weeks, rather than day one?
• What happens if the effect settles unevenly — and is a two-week review offered, rather than something the patient has to request?

Then ask the question that tells you the most: what should not be treated yet?

A provider willing to answer “that area doesn’t need anything” is reading the face, not the price list.

Final Thoughts

Preventative treatment isn’t a race against a birthday, and it isn’t a way to stop aging. It’s a decision about one specific mechanism — repetitive folding — made at the point where the fold starts leaving a mark that doesn’t fade.

For some people that point arrives at twenty-eight. For others, forty-five. The mirror is a better guide than any recommended starting age.

And for anyone whose lines still vanish completely at rest, the most useful thing a good provider can offer is honest reassurance that there’s nothing to treat yet.